MedPath

effect of antioxidants in leprosy

Phase 4
Conditions
Health Condition 1: null- leprosy
Registration Number
CTRI/2017/08/009369
Lead Sponsor
Shri Ram Murti Institute of Medical Sciences Bhojipura Bareilly
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. New Clinically diagnosed or biopsy proven case of multibacillary leprosy.

2. They did not take any antileprosy drugs or antioxidants in preceeding 6 months.

3. Age >= 18 years

4. Patients should be willing for Investigation, Treatment and Regular Follow up

Exclusion Criteria

1) Pregnancy or Lactation at present

2) Hepatic, Renal, Lipid Profile Abnormalities

3) Past/Present history of any type of Malignancy

4) Patient unsure about attending treatment Schedule Regularly

5)Previous H/o any Hypersensitivity Reaction to anti-oxidants

6) Patients who fail to come for follow up after Initiation of therapy

7) Patients with previous H/o Immunobullous disorders and autoimmune diseases

8) Patient is an alcoholic and smoker

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Oxidation stress indexTimepoint: Baseline and after 3 months
Secondary Outcome Measures
NameTimeMethod
noneTimepoint: none
© Copyright 2025. All Rights Reserved by MedPath